相关实验视频

Updated: Jul 12, 2026

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.9K

利用纳米体精确准蛋白质:治疗和诊断领域的机遇和挑战

Elise M Van Fossen1, Oscar Rodriguez1, Madelyn Berger1

  • 1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99354, United States.

ACS chemical biology
|July 25, 2025
PubMed
概括

蛋白形特异性纳米体 (Nbs) 通过向驱动疾病的蛋白质变体,提供了新的诊断和治疗潜力. 蛋白质合成的进步现在使得这些高度特定的Nbs.的工程成为可能.

更多相关视频

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

11.8K
Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

16.4K

相关概念视频

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...